After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Cramer is gearing up for the heaviest week of this earnings season, but he's also providing his game plan for helping you be a better investor.
MIT's Smart 50 list recognizes companies for their combination of innovative technology and effective management, and it includes 13 pharmaceutical and biotech firms this year.
Cramer says Abiomed is too expensive while Harman was hurt by the strong dollar.
Johnson & Johnson was easy, Cramer says, but other stocks were more problematic.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.